Don’t miss the newest presentation in our Advancing Healthcare Webinar Series, The Evolving Role of Anti-Müllerian Hormone Measurement in Clinical Practice.
Reproduction is a significant aspect of life for many people, and infertility can be emotionally devastating. Fortunately, medical advances have made it possible for many infertile couples to bear children. There is a standard hormonal analysis protocol for patients undergoing assisted reproductive technology (ART) that relies on hormonal fluctuations during a menstrual cycle. However, there is one biomarker, Anti-Müllerian Hormone (AMH), that can be measured at any time that provides actionable results regarding an individual’s ovarian reserve and fertility status.
Jaime Noguez, PhD, DABCC will lead the discussion on the evolving role of AMH in clinical applications.
Learning objectives
- Provide an overview of AMH production and the significance of AMH expression.
- Identify methods for AMH measurement.
- Review the clinical application of AMH as a biomarker for ovarian reserve, and future possibilities in women’s health.
Director of Clinical Chemistry & Toxicology: University Hospitals Cleveland Medical Center
Associate Professor, Pathology: Case Western Reserve University School of Medicine
Speaker
Dr.Jaime Noguez
Director of Clinical Chemistry & Toxicology: University Hospitals Cleveland Medical Center
Associate Professor, Pathology: Case Western Reserve University School of Medicine
Dr. Jaime Noguez received her BS in chemistry from Sweet Briar College in Lynchburg, Virginia in 2004. She completed her graduate studies in organic chemistry at the University of South Florida in 2010 followed by a two-year postdoctoral fellowship at the University of Florida in chemical biology. She went on to complete a two-year clinical chemistry fellowship at Emory University in 2014 and is board certified by the American Board of Clinical Chemistry.
